Table 3. A manual selection of compounds with predicted drug target(s) based on similarity in expression profiles to another drug with known target.
Drug | Predicted Target(s) | Predicted targeting pathways |
Ajmaline | KCNMA1 HRH2 | GPCRs in the regulation of smooth muscle tone; G-Protein Coupled Receptor Signaling; cAMP-mediated Signaling |
Cicloheximide | ATP1A1 | Leptin signaling via PI3K-dependent pathway |
Lobeline | KCNMA1 | GPCRs in the regulation of smooth muscle tone |
Quercetin | NR3C2 FKBP1A | Glucocorticoid Receptor Signaling; IL-4 Signaling; Neutrophil and Its Surface Molecules; mTOR Signaling Pathway |
Salbutamol | DRD2 | Regulation of cell cycle progression by Plk3; Dopamine Receptor Signaling; G-Protein Coupled Receptor Signaling; cAMP-mediated Signaling |
Strophanthidin | ATP1A1 | Leptin signaling via PI3K-dependent pathway |
Daunorubicin | TOP2A | Apoptotic DNA fragmentation and tissue homeostasis; Cell Cycle: G2/M DNA Damage Checkpoint Regulation |
The last column is the list of pathways that the target of the known drug participates. Thus, the hypothesis is that the shown drug may act either through the predicted target or at least through the shown pathway.